Zhang D, Zhao Y, Wang T, Xi Y, Li N, Huang H. Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies. Diabetes Metab Res Rev. 2017;33(4):e2868.
Shah MM, Erickson BK, Matin T, McGwin G, Martin JY, Daily LB, Pasko D, Haygood CW, Fauci JM, Leath CA. Diabetes mellitus and ovarian cancer: more complex than just increasing risk. Gynecol Oncol. 2014;135(2):273–7.
Article
PubMed
PubMed Central
Google Scholar
Thomson CA, Crane TE, Wertheim BC, Neuhouser ML, Li W, Snetselaar LG, Basen-Engquist KM, Zhou Y, Irwin ML. Diet quality and survival after ovarian cancer: results from the Women’s health initiative. J Natl Cancer Inst. 2014;106(11):dju314.
Article
PubMed
PubMed Central
Google Scholar
Romero IL, McCormick A, McEwen KA, Park S, Karrison T, Yamada SD, Pannain S, Lengyel E. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstet Gynecol. 2012;119(1):61.
Article
PubMed
PubMed Central
Google Scholar
Stålberg K, Svensson T, Lönn S, Kieler H. The influence of comorbidity on mortality in ovarian cancer patients. Gynecol Oncol. 2014;133(2):298–303.
Article
PubMed
Google Scholar
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J-WW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.
Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, L-m C, Copeland L, Crispens MA, Gershenson DM, Gray HJ, Hakam A. Ovarian cancer, version 2.2013. J Natl Compr Cancer Netw. 2013;11(10):1199–209.
Article
CAS
Google Scholar
Tewari D, Java JJ, Salani R, Armstrong DK, Markman M, Herzog T, Monk BJ, Chan JK. Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study. J Clin Oncol. 2015;33(13):1460–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Purcell SA, Elliott SA, Kroenke CH, Sawyer MB, Prado CM. Impact of body weight and body composition on ovarian cancer prognosis. Curr Oncol Rep. 2016;18(2):8.
Article
PubMed
Google Scholar
Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer. 2007;43(4):690–709.
Article
PubMed
Google Scholar
Yang H-S, Yoon C, Myung S-K, Park SM. Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer. 2011;21(9):1525–32.
Article
PubMed
Google Scholar
Lees B, Leath CA III. The impact of diabetes on gynecologic cancer: current status and future directions. Curr Obstet Gynecol Rep. 2015;4(4):234.
Article
PubMed
PubMed Central
Google Scholar
Vrachnis N, Iavazzo C, Iliodromiti Z, Sifakis S, Alexandrou A, Siristatidis C, Grigoriadis C, Botsis D, Creatsas G. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives. Arch Gynecol Obstet. 2016;293(2):239–46.
Article
CAS
PubMed
Google Scholar
Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Prev Biomarkers. 2005;14(1):98–107.
CAS
Google Scholar
Howe LR, Subbaramaiah K, Hudis CA, Dannenberg AJ. Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res. 2013;19(22):6074–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Joung KH, Jeong J-W, Ku BJ. The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms. Biomed Res Int. 2015;2015:12.
Nagle C, Dixon S, Jensen A, Kjaer S, Modugno F, Fereday S, Hung J, Johnatty S, Fasching P, Beckmann M. Obesity and survival among women with ovarian cancer: results from the ovarian Cancer association consortium. Br J Cancer. 2015;113(5):817–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 DiabetesA systematic review and meta-analysisDiabetes medications as monotherapy or metformin-based combination therapy. Ann Intern Med. 2016;164(11):740–51.
Article
PubMed
Google Scholar
Sinha R, Rauniar G, Panday DR, Adhikari S. METFORMIN: A REVIEW; 2016.
Google Scholar
Febbraro T, Lengyel E, Romero IL. Old drug, new trick: repurposing metformin for gynecologic cancers? Gynecol Oncol. 2014;135(3):614–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumar S, Meuter A, Thapa P, Langstraat C, Giri S, Chien J, Rattan R, Cliby W, Shridhar V. Metformin intake is associated with better survival in ovarian cancer. Cancer. 2013;119(3):555–62.
Article
CAS
PubMed
Google Scholar
Patel S, Kumar L, Singh N. Metformin and epithelial ovarian cancer therapeutics. Cell Oncol. 2015;38(5):2211–3428.
Article
Google Scholar
Gadducci A, Biglia N, Tana R, Cosio S, Gallo M. Metformin use and gynecological cancers: a novel treatment option emerging from drug repositioning. Crit Rev Oncol Hematol. 2016;105:73–83.
Article
PubMed
Google Scholar
Shank JJ, Yang K, Ghannam J, Cabrera L, Johnston CJ, Reynolds RK, Buckanovich RJ. Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecol Oncol. 2012;127(2):390–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li L, Qi X, Xu M, Ding X, Zhou X, Zhang C, Fan Z, Zhao Y, Sheng H, Zhang Y. The effects of metformin on ovarian cancer: an updated systematic review and meta-analysis. Int J Clin Exp Med. 2016;9(9):17559–68.
CAS
Google Scholar
Bakhru A, Buckanovich RJ, Griggs JJ. The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol. 2011;121(1):106–11.
Article
PubMed
Google Scholar
Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc. 2001;60(1):91–106.
Article
CAS
PubMed
Google Scholar
Adler AI, Weiss NS, Kamb ML, Lyon JL. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control. 1996;7(4):475–8.
Article
CAS
PubMed
Google Scholar
Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92(18):1472–89.
Article
CAS
PubMed
Google Scholar
Weiderpass E, Ye W, Vainio H, Kaaks R, Adami H-O. Diabetes mellitus and ovarian cancer (Sweden). Cancer Causes Control. 2002;13(8):759–64.
Article
PubMed
Google Scholar
Coppola D, Saunders B, Fu L, Mao W, Nicosia SV. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression. Cancer Res. 1999;59(13):3264–70.
CAS
PubMed
Google Scholar
Greenwood M, Wood F. The relation between the cancer and diabetes death-rates. Epidemiol Infect. 1914;14(1):83–118.
CAS
Google Scholar
Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer. 2011;47(13):1928–37.
Article
PubMed
Google Scholar
Yang W-S, Va P, Bray F, Gao S, Gao J, Li H-L, Xiang Y-B. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One. 2011;6(12):e27326.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deng L, Gui Z, Zhao L, Wang J, Shen L. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci. 2012;57(6):1576–85.
Article
CAS
PubMed
Google Scholar
Friberg E, Orsini N, Mantzoros C, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365–74.
Article
CAS
PubMed
Google Scholar
Lee J, Giovannucci E, Jeon JY. Diabetes and mortality in patients with prostate cancer: a meta-analysis. Springerplus. 2016;5(1):1548.
Article
PubMed
PubMed Central
Google Scholar
Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013;56(11):1304.
Article
PubMed
PubMed Central
Google Scholar
Lee J-Y, Jeon I, Kim JW, Song Y-S, Yoon J-M, Park SM. Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer. 2013;23(3):402–12.
Article
PubMed
Google Scholar